Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Healthcare Triangle, Inc.

CIK 1839285Updated Sep 27, 2026

HCTI price & chart

Provider market data

Loading TradingView…

NASDAQ:HCTI on TradingView ↗

TradingView · Data may be delayed

About the company

Healthcare Triangle, Inc. delivers advanced digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare providers, payers, and life sciences organizations. HCTI strengthens healthcare delivery through enhanced security, compliance, data analytics, and operational efficiency.

8-K · 2026-07-29 · 0001213900-26-082514

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. POS AM filing

    POS AM · 2026-09-25 · 0001213900-26-103624

  2. Entry into a Material Definitive Agreement

    Items 1.01, 9.01

    8-K · 2026-09-25 · 0001213900-26-103604

  3. Entry into a Material Definitive Agreement

    Items 1.01, 9.01

    8-K · 2026-09-08 · 0001213900-26-097953

  4. 10-Q filing

    10-Q · 2026-08-13 · 0001213900-26-089241

  5. Unregistered Sales of Equity Securities · Regulation FD Disclosure

    Items 3.02, 7.01, 9.01

    8-K · 2026-07-29 · 0001213900-26-082514

Show 5 more recent filings
  1. Submission of Matters to a Vote of Security Holders

    Items 5.07

    8-K · 2026-07-20 · 0001213900-26-079616

  2. 424B3 filing

    424B3 · 2026-07-16 · 0001213900-26-078700

  3. EFFECT filing

    EFFECT · 2026-07-15 · 9999999995-26-002318

  4. S-1 filing

    S-1 · 2026-07-10 · 0001213900-26-077268

  5. RW filing

    RW · 2026-07-09 · 0001213900-26-076690

Financials

FY 2025 · USD
Revenue13,891,000USD · FY 2025
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

Net income-9,476,000USD · FY 2025
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

Operating income-9,789,000USD · FY 2025
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

Diluted EPS-152.3USD per share · FY 2025
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD22,736,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

1,961,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

6,858,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

20,763,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Property, Plant and Equipment, NetUSD5,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

12,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

44,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

As of 2023-12-31

80,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

GoodwillUSD2,946,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

——1,289,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Intangible Assets, Net (Excluding Goodwill)USD——857,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

—
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD7,625,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

20,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

1,234,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

As of 2023-12-31

1,341,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD2,070,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

1,110,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

3,595,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

5,592,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Assets, CurrentUSD13,151,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

1,452,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

5,653,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

7,749,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD—7,075,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

8,249,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

8,375,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD—7,435,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

——
Common Stock, Value, IssuedUSD11,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

—0
Source

10-K · 2024-03-18 · 0001213900-24-023562

As of 2023-12-31

0
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Additional Paid in CapitalUSD45,534,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

21,022,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

26,211,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

24,956,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-42,999,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

-33,571,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

-27,602,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

-12,568,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD—-5,114,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

-1,391,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

12,478,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Liabilities and EquityUSD22,736,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

1,961,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

6,858,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

20,763,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD12,792,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

7,075,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

7,652,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

As of 2023-12-31

6,148,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Accounts Payable, CurrentUSD744,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

2,539,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

1,953,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

As of 2023-12-31

1,481,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD-37,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

———
Additional Financial Items
Accounts Receivable, after Allowance for Credit LossUSD———5,592,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——-401,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

-9,609,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD705,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

889,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

1,566,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

3,374,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD451,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

87,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

166,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD913,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-2,315,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-2,270,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-4,081,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD-16,523,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-1,081,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-2,151,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-2,600,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-1,751,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—-12,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-3,319,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD6,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—12,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Cash flows from financing activities:
Payments for Repurchase of Common StockUSD———142,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Financing ActivitiesUSD25,879,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-133,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

2,056,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

5,490,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD7,625,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

20,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

As of 2024-12-31

1,234,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

As of 2023-12-31

1,341,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD—121,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

968,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

—
Income Taxes Paid, NetUSD—12,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

35,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD451,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

—257,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Amortization of Debt Issuance Costs and DiscountsUSD223,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—435,000,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Amortization of Intangible AssetsUSD—857,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

1,518,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

3,167,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

AssetAcquisitionContingentConsiderationLiabilityUSD———2,227,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

DepreciationUSD13,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

32,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

48,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

35,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Fair Value, Option, Changes in Fair Value, Gain (Loss)USD41,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Foreign Currency Transaction Gain (Loss), before TaxUSD-18,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD7,337,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

3,950,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

5,727,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

5,575,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

GoodwillUSD2,946,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

As of 2025-12-31

——1,289,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

As of 2022-12-31

Goodwill, Impairment LossUSD—0
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

2,385,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD9,789,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

——-10,414,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD-37,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—-35,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD—12,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

35,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

63,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD-9,476,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-5,969,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-8,686,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-9,610,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD-37,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Net Income (Loss) Available to Common Stockholders, BasicUSD9,428,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—-8,686,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-9,609,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Operating ExpensesUSD11,679,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

7,641,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

14,472,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

21,711,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD9,825,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—500,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

5,888,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD——0
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

29,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Financing Receivable, Credit Loss, Expense (Reversal)USD17,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Revenue from Contract with Customer, Including Assessed TaxUSD———45,886,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Unrealized Gain (Loss) on InvestmentsUSD27,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Total RevenueUSD13,891,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

11,696,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

33,203,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

45,886,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Cost of Goods and Services Sold————
Selling, General and Administrative ExpenseUSD———0
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Operating Income (Loss)USD-9,789,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-4,751,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-7,695,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-10,416,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-9,476,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-5,957,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-8,651,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-9,547,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD—12,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

35,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

63,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD-37,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD-9,476,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-5,969,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-8,686,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-9,610,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share-152.3
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-1.13
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-2.08
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Earnings Per Share, DilutedUSD per share-152.3
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-1.13
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-2.08
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Weighted Average Number of Shares Outstanding, Basicshares61,873
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

5,278,293
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

4,179,140
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Weighted Average Number of Shares Outstanding, Dilutedshares61,873
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

5,278,293
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

4,179,140
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Additional Financial Items
Amortization of Intangible AssetsUSD—857,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

1,518,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

3,167,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Current Income Tax Expense (Benefit)USD——0
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

63,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Depreciation, Depletion and Amortization, NonproductionUSD705,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—1,566,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

3,374,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Fair Value, Option, Changes in Fair Value, Gain (Loss)USD41,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Foreign Currency Transaction Gain (Loss), before TaxUSD-18,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD7,337,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

3,950,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

5,727,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

5,575,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Goodwill, Impairment LossUSD—0
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

2,385,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Gross ProfitUSD1,235,000,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

1,070,000,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

1,070,000,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

—
Income (Loss) Attributable to Parent, before TaxUSD——-8,651,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD9,789,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

——-10,414,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD-37,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—-35,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

—
Interest ExpenseUSD567,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

——212,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Interest Expense, DebtUSD——968,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

211,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Interest Income (Expense), NetUSD-567,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

-1,213,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

-968,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

-212,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Marketing and Advertising ExpenseUSD———6,808,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD9,428,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

—-8,686,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

-9,609,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Operating ExpensesUSD11,679,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

7,641,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

14,472,000
Source

10-K/A · 2025-02-18 · 0001213900-25-014503

2023-01-01 to 2023-12-31

21,711,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Other ExpensesUSD1,215,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

———
Other IncomeUSD857,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

7,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

12,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

1,081,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD536,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

429,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

799,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

5,953,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Revenue from Contract with Customer, Including Assessed TaxUSD———45,886,000
Source

10-K · 2023-03-28 · 0001607062-23-000154

2022-01-01 to 2022-12-31

Selling and Marketing ExpenseUSD3,084,000
Source

10-K · 2026-04-15 · 0001213900-26-044078

2025-01-01 to 2025-12-31

2,203,000
Source

10-K · 2025-03-31 · 0001213900-25-026218

2024-01-01 to 2024-12-31

4,670,000
Source

10-K · 2024-03-18 · 0001213900-24-023562

2023-01-01 to 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-297397

POS AM · 2026-09-25 · 0001213900-26-103624

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ea029955101ex99-1.htm · 8-K · 2026-07-29

EX-99.1 2 ea029955101ex99-1.htm PRICING PRESS RELEASE DATED JULY 29, 2026 Exhibit 99.1 Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq’s New $5 Million Market Value Listing Standard Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq’s newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif. …

8-K · 2026-07-29 · 0001213900-26-082514

Read attachment ↗
ea029478001ex4-1.htm · 8-K · 2026-06-15

EX-4.1 2 ea029478001ex4-1.htm FORM OF ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 12, 2026 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUAN…

8-K · 2026-06-15 · 0001213900-26-068871

Read attachment ↗
ea029478001ex4-2.htm · 8-K · 2026-06-15

EX-4.2 3 ea029478001ex4-2.htm COMMON STOCK PURCHASE WARRANT ISSUED TO HUDSON GLOBAL VENTURES, LLC, DATED JUNE 12, 2026 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS…

8-K · 2026-06-15 · 0001213900-26-068871

Read attachment ↗
ea029478001ex99-1.htm · 8-K · 2026-06-15

EX-99.1 7 ea029478001ex99-1.htm PRESS RELEASE, DATED JUNE 12, 2026 Exhibit 99.1 Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million PLEASANTON, Calif., June 12, 2026 (PR NEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of…

8-K · 2026-06-15 · 0001213900-26-068871

Read attachment ↗